Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma von Ramirez‐Fort, M. K., Meier‐Schiesser, B., Lachance, K., Mahase, S. S., Church, C. D., Niaz, M. J., Liu, H., Navarro, V., Nikolopoulou, A., Kazakov, D. V., Contassot, E., Nguyen, D. P., Sach, J., Hadravsky, L., Sheng, Y., Tagawa, S. T., Wu, X., Lange, C. S., French, L. E., Nghiem, P. T., Bander, N. H.

Volltext

Lynch Syndrome -  the Pathologist's Diagnosis von Dušek, M, Hadravský, L, Černá, K, Stehlík, J, Švajdler, M, Kokošková, B, Dubová, M, Michal, M, Daum, O

Volltext

Muir-Torre syndrome--a phenotypic variant of Lynch syndrome von Kacerovská, D, Kazakov, D V, Cerná, K, Hadravský, L, Michal, Jr, M, Dostál, J, Skálová, Jr, A, Michal, M

Volltext

Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma von Ramirez‐Fort, Marigdalia K, Meier‐Schiesser, Barbara, Lachance, Kristina, Mahase, Sean S, Church, Candice D, Niaz, Muhammad J, Liu, Huixian, Navarro, Vicente, Nikolopoulou, Anastasia, Kazakov, Dmitry V, Contassot, Emmanuel, Nguyen, Daniel P, Sach, J, Hadravsky, L, Sheng, Yinxiangzi, Tagawa, Scott T, Wu, Xianwei, Lange, Christopher S, French, Lars E, Nghiem, Paul T, Bander, Neil H

Volltext